Steve Kornher

Jan 13, 2025 | cellandgene.com | Steve Kornher |Shanti Chari |Junwei Sun |Lucia Fernandez |Lucia Fernández

With over 450 unique products in clinical development and 50 anticipated approvals by 2030, the evolving regulatory landscape for cell and gene therapies is more critical than ever. Don't miss your chance to gain expert insights! Join the next Cell & Gene Live for an exclusive digital panel discussion exploring forward-looking perspectives on this transformative field. Registration is free—thanks to the support of Thermo Fisher Scientific.

Oct 29, 2023 | clinicalleader.com | Steve Kornher

By Steve Kornher, Ph.D. For pre-clinical or early-stage biopharma companies, the choice of a Contract Manufacturing Organization (CMO) is a pivotal decision that can significantly impact their future success. Opting for the right partner hinges on the ability to carefully assess and weigh the trade-offs presented by each potential manufacturer.